French Biotech Launches Phase III Global Trial for Lung Cancer Drug
OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will…
08/02/2016 - 2 minutes
OSE Immunotherapeutics
3 French Bioentrepreneurs are Awarded for Being Stubborn
Building a company is extremely difficult and obstination is sometimes needed to reach success. The…
07/01/2016 - 3 minutes
How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…
By targeting platinum resistant Ovarian cancer, Avelumab is a new anti-PD-L1 checkpoint inhibitor on the…
05/01/2016 - 3 minutes
France’s leading Female Bio-entrepreneur joins board of Abivax
Dominique Costantini is one of France's leading biotech figures, with over 20 years experience on…
17/09/2015 - 2 minutes
Encouraging results from Tedopi Phase II trials in patients with brain metastases
French Immuno-oncology Biotech OSE Pharma has announced its phase II results for Tedopi trials showing…
09/09/2015 - 2 minutes
Paris is Europe’s biggest Biocluster, but nobody knows it …
Paris is well-known for being the most beautiful city in the world. But did you…
19/08/2015 - 5 minutes
OSE Pharma raised €21.1 Million
OSE Pharma’s Initial Public Offering couldn’t have been more successful as it just raised €21.1M.…
27/03/2015 - 1 minute
The Promising Company OSE Pharma launches an IPO
Created in 2012 by Emile Loria and Dominique Costantini, OSE Pharma is a European cancer…
10/03/2015 - 3 minutes
